{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T15:22:05Z","timestamp":1771600925775,"version":"3.50.1"},"reference-count":17,"publisher":"Informa UK Limited","issue":"5-6","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000406","name":"MND Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022572","name":"NIHR Sheffield Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022572","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000406","name":"Motor Neuron Disease Association","doi-asserted-by":"crossref","award":["McNeill\/Oct21\/967-794"],"award-info":[{"award-number":["McNeill\/Oct21\/967-794"]}],"id":[{"id":"10.13039\/501100000406","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"],"published-print":{"date-parts":[[2025,7,3]]},"DOI":"10.1080\/21678421.2025.2469727","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T09:42:39Z","timestamp":1740649359000},"page":"436-443","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Exploring the needs and preferences of people with amyotrophic lateral sclerosis (ALS) when making genomic testing decisions: an interview study"],"prefix":"10.1080","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7182-593X","authenticated-orcid":false,"given":"Jade","family":"Howard","sequence":"first","affiliation":[{"name":"Sheffield Institute for Translational Neuroscience, Division of Neuroscience, The University of Sheffield","place":["Sheffield, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1978-5795","authenticated-orcid":false,"given":"Hilary L.","family":"Bekker","sequence":"additional","affiliation":[{"name":"Leeds Unit of Complex Intervention Development (LUCID), Leeds Institute of Health Sciences, School of Medicine, University of Leeds","place":["Leeds, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1269-9053","authenticated-orcid":false,"given":"Christopher J.","family":"McDermott","sequence":"additional","affiliation":[{"name":"Sheffield Institute for Translational Neuroscience, Division of Neuroscience, The University of Sheffield","place":["Sheffield, UK"]},{"name":"Academic Directorate of Neuroscience, Royal Hallamshire Hospital","place":["Sheffield, UK, and"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5702-3631","authenticated-orcid":false,"given":"Alisdair","family":"McNeill","sequence":"additional","affiliation":[{"name":"Sheffield Institute for Translational Neuroscience, Division of Neuroscience, The University of Sheffield","place":["Sheffield, UK"]},{"name":"Sheffield Clinical Genetics Service","place":["Sheffield, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"NHS. National genomic test directory testing criteria for rare and inherited disease. 2023. v5.2 June 2023. Available at: https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2018\/08\/Rare-and-inherited-disease-eligibility-criteria-version-5.2.pdf."},{"key":"e_1_3_3_3_1","unstructured":"NHS. Accelerating genomic medicine in the NHS: NHS England. 2022 Available at: https:\/\/www.england.nhs.uk\/long-read\/accelerating-genomic-medicine-in-the-nhs\/."},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-325014"},{"key":"e_1_3_3_5_1","unstructured":"Biogen. Biogen receives European commission approval for QALSODY\u00ae (tofersen) the first therapy to treat a rare genetic form of ALS: biogen. 2024 Available at: https:\/\/investors.biogen.com\/news-releases\/news-release-details\/biogen-receives-european-commission-approval-qalsodyr-tofersen."},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2023.2299204"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg-2023-109735"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/jgc4.1591"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.4540"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2022.2150556"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2019.1582670"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003686"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2021-107776"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/1049732315617444"},{"key":"e_1_3_3_15_1","volume-title":"Qualitative research practice, a guide for social science students & researchers","author":"Ritchie J","year":"2014","unstructured":"Ritchie J, Lewis J, McNaughton Nicholls C, Ormston R. Qualitative research practice, a guide for social science students & researchers. 2nd ed. London: SAGE; 2014.","edition":"2"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51895"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S36759"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-016-0034-y"}],"container-title":["Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21678421.2025.2469727","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T15:51:35Z","timestamp":1753199495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21678421.2025.2469727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":17,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2025,7,3]]}},"alternative-id":["10.1080\/21678421.2025.2469727"],"URL":"https:\/\/doi.org\/10.1080\/21678421.2025.2469727","relation":{},"ISSN":["2167-8421","2167-9223"],"issn-type":[{"value":"2167-8421","type":"print"},{"value":"2167-9223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iafd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iafd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-12-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}